Rose AAN - Search Results

1

HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin.

Biondini M, Kiepas A, El-Houjeiri L, Annis MG, Hsu BE, Fortier AM, Morin G, Martina JA, Sirois I, Aguilar-Mahecha A, Gruosso T, McGuirk S, Rose AAN, Tokat UM, Johnson RM, Sahin O, Bareke E, St-Pierre J, Park M, Basik M, Majewski J, Puertollano R, Pause A, Huang S, Keler T, Siegel PM. Biondini M, et al. Among authors: rose aan. Oncogene. 2022 Mar;41(12):1701-1717. doi: 10.1038/s41388-022-02206-z. Epub 2022 Feb 2. Oncogene. 2022. PMID: 35110681

2

Breast cancer-derived factors facilitate osteolytic bone metastasis.

Rose AA, Siegel PM. Rose AA, et al. Bull Cancer. 2006 Sep;93(9):931-43. Bull Cancer. 2006. PMID: 16980236 Free article. Review.

3

Osteoactivin promotes breast cancer metastasis to bone.

Rose AA, Pepin F, Russo C, Abou Khalil JE, Hallett M, Siegel PM. Rose AA, et al. Mol Cancer Res. 2007 Oct;5(10):1001-14. doi: 10.1158/1541-7786.MCR-07-0119. Mol Cancer Res. 2007. PMID: 17951401

4

Osteoactivin/HGFIN: is it a tumor suppressor or mediator of metastasis in breast cancer?

Rose AA, Siegel PM. Rose AA, et al. Breast Cancer Res. 2007;9(6):403. doi: 10.1186/bcr1791. Breast Cancer Res. 2007. PMID: 18086324 Free PMC article. No abstract available.

5

GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis.

Dydensborg AB, Rose AA, Wilson BJ, Grote D, Paquet M, Giguère V, Siegel PM, Bouchard M. Dydensborg AB, et al. Oncogene. 2009 Jul 23;28(29):2634-42. doi: 10.1038/onc.2009.126. Epub 2009 Jun 1. Oncogene. 2009. PMID: 19483726

6

Emerging therapeutic targets in breast cancer bone metastasis.

Rose AA, Siegel PM. Rose AA, et al. Future Oncol. 2010 Jan;6(1):55-74. doi: 10.2217/fon.09.138. Future Oncol. 2010. PMID: 20021209 Free article. Review.

7

Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.

Rose AA, Grosset AA, Dong Z, Russo C, Macdonald PA, Bertos NR, St-Pierre Y, Simantov R, Hallett M, Park M, Gaboury L, Siegel PM. Rose AA, et al. Clin Cancer Res. 2010 Apr 1;16(7):2147-56. doi: 10.1158/1078-0432.CCR-09-1611. Epub 2010 Mar 9. Clin Cancer Res. 2010. PMID: 20215530

8

Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells.

Demers M, Rose AA, Grosset AA, Biron-Pain K, Gaboury L, Siegel PM, St-Pierre Y. Demers M, et al. Am J Pathol. 2010 Jun;176(6):3023-31. doi: 10.2353/ajpath.2010.090876. Epub 2010 Apr 9. Am J Pathol. 2010. PMID: 20382700 Free PMC article.

9

Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.

Bemmo A, Dias C, Rose AA, Russo C, Siegel P, Majewski J. Bemmo A, et al. PLoS One. 2010 Aug 6;5(8):e11981. doi: 10.1371/journal.pone.0011981. PLoS One. 2010. PMID: 20700505 Free PMC article.

10

ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties.

Rose AA, Annis MG, Dong Z, Pepin F, Hallett M, Park M, Siegel PM. Rose AA, et al. PLoS One. 2010 Aug 10;5(8):e12093. doi: 10.1371/journal.pone.0012093. PLoS One. 2010. PMID: 20711474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page